OSR Health, Inc.
OSRH- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001840425
No open-market purchases or sales by OSR Health, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $210.6K in total; no superinvestor holds it.
Other share classesOSRHW
13F holders, Q2 2026
Institutional positions in OSR Health, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +3 vs. Q1 2026
- Shares held
- 667.0K
- +374.1K (+127.7%) vs. Q1 2026
- Total value
- $210.6K
- +$33.5K (+18.9%) vs. Q1 2026
- New holders
- 6
- 3 more added
- Sold out
- 3
- 3 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OSRH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $210.6K |
| Q1 2026 | 11 | $177.1K |
| Q4 2025 | 11 | $97.3K |
| Q3 2025 | 8 | $120.4K |
| Q2 2025 | 8 | $120.7K |
| Q1 2025 | 8 | $118.2K |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding OSR Health, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Fiduciary Trust Co | 148,266 | $46.9K | 0.00% | +131,237+770.7% | Added |
| Citadel Advisors LLC | 127,810 | $40.4K | 0.00% | +127,810 | New |
| Jane Street Group, LLC | 127,195 | $40.2K | 0.00% | +127,195 | New |
| Geode Capital Management, LLC | 100,458 | $31.8K | 0.00% | −5,285−5.0% | Reduced |
| Two Sigma Securities, LLC | 46,537 | $14.7K | 0.00% | +46,537 | New |
| Vanguard Capital Management LLC | 37,373 | $11.8K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 32,380 | $10.2K | 0.00% | −28,366−46.7% | Reduced |
| Susquehanna International Group, LLP | 18,282 | $5.78K | 0.00% | +18,282 | New |
| Northern Trust Corp | 10,906 | $3.45K | 0.00% | +10,906 | New |
| Tower Research Capital LLC (TRC) | 6,587 | $2.08K | 0.00% | +2,446+59.1% | Added |
| Mint Tower Capital Management B.V. | 7,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| SkyView Investment Advisors, LLC | 3,000 | $1.00K | 0.00% | +3,000 | New |
| UBS Group AG | 580 | $183 | 0.00% | −3,896−87.0% | Reduced |
| SBI Securities Co., Ltd. | 137 | $43 | 0.00% | +60+77.9% | Added |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −15,435−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −384−100.0% | Sold out |